Andrew Mackenzie
Plus aucun poste en cours
Profil
Andrew Mackenzie worked as a Director of Research & Development at InnerDyne Medical, Inc., a Technical Project Leader at Guidant Corp., a General Manager at Perfect Surgical Techniques, Inc., the Head of Quality, Clinical & Regulatory Affairs at Sadra Medical, Inc., the Vice President of Research & Development at StemCor Systems, Inc., and the Chief Operating Officer at BioCardia, Inc. He holds an MBA from Santa Clara University, a graduate degree from the University of California, Berkeley, and an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Anciens postes connus de Andrew Mackenzie
| Sociétés | Poste | Fin |
|---|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Corporate Officer/Principal | - |
InnerDyne Medical, Inc.
 InnerDyne Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson Controls International Plc, InnerDyne Medical, Inc. is a company that produces proprietary medical devices. The company is based in Sunnyvale, CA. InnerDyne Medical was acquired by CardioPulmonics, Inc. on January 26, 1994. | Directeur Technique/Scientifique/R&D | - |
| Perfect Surgical Techniques, Inc. | Corporate Officer/Principal | - |
Sadra Medical, Inc.
 Sadra Medical, Inc. Medical SpecialtiesHealth Technology Sadra Medical, Inc. develops therapies for treatment of aortic valve diseases. The company was founded by Fred Khosravi and Amr Salahieh in 2003 and is headquartered in Marlborough, MA. | Directeur Technique/Scientifique/R&D | - |
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Directeur Technique/Scientifique/R&D | - |
Formation de Andrew Mackenzie
| Santa Clara University | Masters Business Admin |
| University of California, Berkeley | Graduate Degree |
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
| Perfect Surgical Techniques, Inc. | |
Sadra Medical, Inc.
Sadra Medical, Inc. Medical SpecialtiesHealth Technology Sadra Medical, Inc. develops therapies for treatment of aortic valve diseases. The company was founded by Fred Khosravi and Amr Salahieh in 2003 and is headquartered in Marlborough, MA. | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
InnerDyne Medical, Inc.
InnerDyne Medical, Inc. Medical SpecialtiesHealth Technology Part of Johnson Controls International Plc, InnerDyne Medical, Inc. is a company that produces proprietary medical devices. The company is based in Sunnyvale, CA. InnerDyne Medical was acquired by CardioPulmonics, Inc. on January 26, 1994. | Health Technology |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | Health Technology |